Training for health staff on new vax begins

Nashik: Nashik and Jalgaon administrations on Wednesday conducted a training of vaccinators, who would be involved in administering the new ZyCov-D vaccine with the needleless injectors.

WHO consultants held demonstrations using soft balls to show the process. Over 200 health workers from the district were given the training at the Nashik district civil hospital. The health officials said that the training will continue even on Thursday. In Jalgaon district too, training was given to over 40 vaccinators for two hours.

“This is the different kind of vaccine given using a needle-free device. The training was given to the health workers about administering this vaccine,” said health officials in Nashik.

The officials said that over five lakh beneficiaries are expected to be given this needle-free vaccine altogether in Nashik and Jalgaon districts.

“The training in both the districts will be over by Thursday. We are expecting that needle-free vaccination will begin in both the districts after December 15. The state government wants to complete vaccination of all the beneficiaries at the earliest,” said health officials.

“It was an interesting training session. So far, we have been administering traditional needle-based vaccines, but this is a different kind of needle-free vaccine. We were given detailed information about the vaccine and also a demonstration,” said a healthcare worker, who attended the training.

Beneficiaries opting for ZyCoV-D have to take three doses, the second one after 28 days and the third one after 56 days.

  • Related Posts

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    In a landmark ruling that will have far-reaching implications for the pharmaceutical sector, the High Court of Himachal Pradesh has quashed three criminal complaints filed by the Central Drugs Standard…

    Eli Lilly launches cancer drug Tanstrive in India

    New Delhi: Eli Lilly and Company India on Thursday announced the launch of its cancer treatment drug Tanstrive in India. The launch follows marketing authorisation from the Central Drugs Standard Control Organisation…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    Eli Lilly launches cancer drug Tanstrive in India

    Eli Lilly launches cancer drug Tanstrive in India

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility